{"id":3578,"date":"2021-01-27T08:41:17","date_gmt":"2021-01-27T08:41:17","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=3578"},"modified":"2021-01-27T08:41:25","modified_gmt":"2021-01-27T08:41:25","slug":"cuba-will-vaccinate-its-entire-population-against-covid-19-in-2021","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cuba-will-vaccinate-its-entire-population-against-covid-19-in-2021\/","title":{"rendered":"Cuba will vaccinate its entire population against COVID-19 in 2021"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"700\" height=\"406\" src=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?resize=700%2C406&#038;ssl=1\" alt=\"\" class=\"wp-image-3579\" srcset=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?w=700&amp;ssl=1 700w, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?resize=300%2C174&amp;ssl=1 300w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><figcaption>The BioCubaFarma enterprise group is adjusting capacity to make possible the administration of Soberana 02 to more than 150,000 persons, while a new clinical trial with children has been launched, as more steps are taken along the path to vaccinating the entire population. Photo: BioCubaFarma<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Eduardo Mart\u00ednez, president of the BioCubaFarma state pharmaceutical enterprise group, reports that work is advancing to expand production capacity of Cuba\u2019s candidate vaccine Soberana 02<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cuba\u2019s national public health system is waging a hard battle against the new coronavirus, sparing no effort and overcoming physical and intellectual fatigue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Party and government\u2019s strong political will has made this possible, along with the impressive work of our scientists who have again reiterated that Cuba will be among the first countries in the world to vaccinate its entire population in 2021, despite the tightening of the U.S. blockade of the island over the past 12 months, stated Dr. Eduardo Mart\u00ednez D\u00edaz, president of the BioCubaFarma state pharmaceutical enterprise group, on his Twitter account.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The general director of the Finlay Vaccine Institute, Dr. Vicente V\u00e9rez Bencomo, has reported that the country is preparing capacity to produce 100 million doses of the injectable Soberana 02 vaccine against COVID-19.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Regarding this announcement, Dr. Mar\u00eda Eugenia Toledo Roman\u00ed, epidemiologist at the Pedro Kour\u00ed Institute of Tropical Medicine (IPK), condemned the escalating sanctions imposed by the United States which have a negative impact on the effort to expand capacity toward this end, stating, \u201cIf we are obliged to purchase new machinery and erect more plants, this is extremely difficult given the limitations we face in acquiring the technologies.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This is why BioCubaFarma is taking advantage of its international experience to sign agreements with other countries that can help with the needed resources and allow the project to advance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Toledo additionally explained, \u201cTo conduct a Phase 3 clinical study of efficacy, in which we show that vaccinated subjects are less likely to become ill than those who were not vaccinated, we must measure this aspect and then make comparisons to find the necessary statistical evidence to finally determine that the candidate vaccine is no less effective than others on the world market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>SPARING NO EFFORT<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Currently underway on the island is a Phase 2b expanded clinical trial<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">of the candidate vaccine Soberana 02 in persons between 19 and 80 years of age, in the Havana municipalities of La Lisa and Plaza de la Revoluci\u00f3n.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Mayra Garc\u00eda Carmenate, research coordinator at the 19 de Abril neighborhood polyclinic, explained that the site was selected for the trials because the facility has met the standard prerequisite of systematically adhering to \u201cbest practices,\u201d and has participated in several months of training to prepare staff members involved and subjects who will receive either the vaccine or a placebo.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After administration of the vaccine, participants will remain under observation for one hour to evaluate any adverse side effects and will be actively monitored via out-patient follow up visits for a period of 28 days. If any reaction should occur, the subject is to immediately return to the clinic where a 24-hour medical post will be maintained to evaluate the situation and, if necessary, transfer the subject to the appropriate public health facility.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Garc\u00eda noted that the community\u2019s population is very enthusiastic and many have made their way to the clinic to volunteer. They have confidence in Cuba\u2019s public health system and those selected are proud of their participation and the fact that their neighborhood was chosen for this type of clinical trial, she said, adding \u201cNone of those chosen during the recruitment have declined to sign the informed consent agreement.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Volunteers and technical personnel alike are confident that Cuban science will defeat COVID-19 with intelligence and dedication.<\/p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">source: <a href=\"http:\/\/en.granma.cu\/cuba\/2021-01-26\/cuba-will-vaccinate-its-entire-population-against-covid-19-in-2021\" data-type=\"URL\" data-id=\"http:\/\/en.granma.cu\/cuba\/2021-01-26\/cuba-will-vaccinate-its-entire-population-against-covid-19-in-2021\" target=\"_blank\" rel=\"noreferrer noopener\">Granma<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Eduardo Mart\u00ednez, president of the BioCubaFarma state pharmaceutical enterprise group, reports that work is advancing to expand production capacity of Cuba\u2019s candidate vaccine Soberana<a class=\"moretag\" href=\"https:\/\/www.cubasupport.ie\/latest\/cuba-will-vaccinate-its-entire-population-against-covid-19-in-2021\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":3,"featured_media":3579,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[36,43],"tags":[],"class_list":["post-3578","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19","category-featured"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":2601,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-moves-closer-to-our-own-covid-19-vaccine\/","url_meta":{"origin":3578,"position":0},"title":"Cuba moves closer to our own COVID-19 vaccine","author":"Editorial Team","date":"August 22, 2020","format":false,"excerpt":"Authorization granted to the Finlay Vaccine Institute to begin clinical trials of new vaccine in collaboration with Ministry of Public Health institutions This past July 28, Cuba\u2019s candidate vaccine was tested for the first time on human volunteers, precisely three researchers participating in its development. An initial evaluation revealed a\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vacine-cuba.jpg?fit=700%2C466&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vacine-cuba.jpg?fit=700%2C466&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vacine-cuba.jpg?fit=700%2C466&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vacine-cuba.jpg?fit=700%2C466&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2527,"url":"https:\/\/www.cubasupport.ie\/latest\/biofarma-innovations-a-new-joint-enterprise-created-by-biocubafarma-and-sg-innovations-limited\/","url_meta":{"origin":3578,"position":1},"title":"BioFarma Innovations, a new joint enterprise created by BioCubaFarma and SG Innovations Limited","author":"Editorial Team","date":"August 4, 2020","format":false,"excerpt":"The new partnership aims to provide broader access to BioCubaFarma's patent-protected portfolio of biopharmaceutical products, developed by the pharmaceutical and biotechnology industry in Cuba Photo: BioCubaFarma Cuba\u2019s BioCubaFarma Enterprise Group and the British company SG Innovations Limited has announced the creation of a new company, BioFarma Innovations, focused on accelerating\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027279.jpg?fit=700%2C481&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027279.jpg?fit=700%2C481&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027279.jpg?fit=700%2C481&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027279.jpg?fit=700%2C481&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3377,"url":"https:\/\/www.cubasupport.ie\/latest\/under-the-radar-and-at-warp-speed-cuba-leads-latin-america-towards-affordable-covid-19-vaccines\/","url_meta":{"origin":3578,"position":2},"title":"Under the Radar and at Warp Speed Cuba Leads Latin America Towards Affordable Covid-19 Vaccines","author":"Editorial Team","date":"December 19, 2020","format":false,"excerpt":"Recently Amy\u00a0Goodman\u2019s \u201cDemocracy Now\u201d\u00a0explored\u00a0\u201cThe Case for People\u2019s Vaccines.\u201d While those interviewed by Ms. Goodman called for early and affordable access to inoculations in the Global South, no mention was made of perhaps the most promising source of such therapies. The neglected source was not only promising, but implicitly revealed the\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_6234-scaled.jpg?fit=1200%2C900&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_6234-scaled.jpg?fit=1200%2C900&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_6234-scaled.jpg?fit=1200%2C900&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_6234-scaled.jpg?fit=1200%2C900&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_6234-scaled.jpg?fit=1200%2C900&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":3992,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-vaccine-revolution-the-island-of-freedom-developing-whopping-five-anti-covid-jabs\/","url_meta":{"origin":3578,"position":3},"title":"Cuba&#8217;s Vaccine Revolution: The Island of Freedom Developing Whopping Five Anti-COVID Jabs","author":"Editorial Team","date":"March 26, 2021","format":false,"excerpt":"While the EU is struggling to stockpile enough anti-COVID jabs, Cuba, a small Caribbean island nation surviving a decades-long US trade embargo, kicked off Phase 3 testing of its own vaccine coronavirus candidates, Soberana 02 and Abdala, earlier this month. Cuba is developing five anti-COVID vaccines. Three of them, Soberana\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-Vaccines-Candidates.png?fit=1200%2C647&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-Vaccines-Candidates.png?fit=1200%2C647&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-Vaccines-Candidates.png?fit=1200%2C647&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-Vaccines-Candidates.png?fit=1200%2C647&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-Vaccines-Candidates.png?fit=1200%2C647&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":4712,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-abdala-vaccine-proved-92-28-effective-in-last-stage-clinical-trials\/","url_meta":{"origin":3578,"position":4},"title":"Cuba&#8217;s Abdala vaccine proved 92.28% effective in last-stage clinical trials.","author":"Editorial Team","date":"June 22, 2021","format":false,"excerpt":"Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials. The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses. \"Hit by the pandemic, our scientists\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1393,"url":"https:\/\/www.cubasupport.ie\/latest\/biocubafarma-in-the-covid-19-battle\/","url_meta":{"origin":3578,"position":5},"title":"BioCubaFarma in the COVID-19 battle","author":"Editorial Team","date":"April 16, 2020","format":false,"excerpt":"To learn about progress being made in scientific research to identify new products to treat COVID-19, Granma interviews Dr. Eduardo Mart\u00ednez D\u00edaz, president of BioCubaFarma Enterprise Group Photo: Ricardo L\u00f3pez Hevia To learn about progress being made in scientific research to identify new products to treat COVID-19, Granma interviews Dr.\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/biofarm.jpg?fit=700%2C466&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/biofarm.jpg?fit=700%2C466&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/biofarm.jpg?fit=700%2C466&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/biofarm.jpg?fit=700%2C466&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-VI","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=3578"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3578\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/3579"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=3578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=3578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=3578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}